en
Scientific article
Comment
Open access
English

Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

Published inNeurology, vol. 98, no. 11, 471
Publication date2022-03-15
Abstract

Comment on

eng
Keywords
  • Humans
  • Immunologic Factors / adverse effects
  • Intermediate Filaments
  • Multiple Sclerosis / blood
  • Multiple Sclerosis, Relapsing-Remitting / blood
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Natalizumab / adverse effects
Citation (ISO format)
BRIDEL, Claire, KILLESTEIN, Joep, TEUNISSEN, Charlotte. Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. In: Neurology, 2022, vol. 98, n° 11, p. 471. doi: 10.1212/WNL.0000000000200133
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0028-3878
99views
7downloads

Technical informations

Creation12/16/2022 7:27:00 AM
First validation12/16/2022 7:27:00 AM
Update time03/16/2023 10:54:18 AM
Status update03/16/2023 10:54:17 AM
Last indexation01/17/2024 11:14:34 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack